HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction?

HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction?

The incidence of human papillomavirus (HPV)-related head and neck cancer (HNSCC) is rising globally, presenting challenges for optimized clinical management. To date, it remains unclear which biomarker best reflects HPV-driven carcinogenesis, a process that is associated with better therapeutic resp...

Full description

Bibliographic Details
Main Authors: Jan Philipp Kühn, Wendelin Schmid, Sandrina Körner, Florian Bochen, Silke Wemmert, Hugo Rimbach, Sigrun Smola, Julia Caroline Radosa, Mathias Wagner, Luc G.T. Morris, Victoria Bozzato, Alessandro Bozzato, Bernhard Schick, Maximilian Linxweiler
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
head and neck cancer
HPV
prognosis
biomarker
p16
Online Access:https://www.mdpi.com/2072-6694/13/18/4730

Internet

https://www.mdpi.com/2072-6694/13/18/4730

Similar Items